Inhibition of TRPV1 attenuates innate nasal epithelial responses via NF-κB signaling pathway in allergic rhinitis
International Immunopharmacology · 2025-06 · 158 · 114807
DOI: 10.1016/j.intimp.2025.114807 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Yanjie Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, the Second Hospital, Shanxi Medical University,Taiyuan, China; Key Research Laboratory of Airway …. Hauptthemen laut MEDLINE: TRPV Cation Channels, Rhinitis, Allergic, NF-kappa B, Nasal Mucosa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanxi Provincial Key Research and Development Project.
Abstract (Originalsprache)
OBJECTIVES: Nasal epithelial cells initiate innate responses to allergens by releasing IL-1 family cytokines, such as IL-33, and disrupting the mucosal barrier. TRPV1 has gained increasing recognition for its role in immune modulation in allergic conditions. This study aimed to elucidate the mechanisms by which epithelial cells detect allergens and explore the pivotal role of TRPV1 in regulating innate nasal epithelial responses. METHODS: To identify TRPV1-related genes and pathways, the GSE167225 dataset was analyzed. To validate TRPV1 expression, clinical data and nasal tissues from 34 patients with AR and 13 controls were collected. To further investigate its mechanisms, OVA-sensitized C57BL/6 mice were exposed to the TRPV1 antagonist SB-705498, and TRPV1 knockout mice were utilized. Primary human nasal epithelial cells were used for in vitro experiments, and various assays, including reverse transcription polymerase chain reaction(RT-PCR), western blotting(WB), and others, were performed to assess gene expression and signaling pathways. RESULTS: Bioinformatics and clinical analysis revealed elevated TRPV1 expression in patients with AR, positively correlated with nasal itching and sneezing severity(R = 0.6493, P < 0.001; R = 0.4906, P < 0.001). In vivo, SB-705498 and TRPV1 ablation significantly alleviated allergy symptoms, reduced allergen-induced IL-33 release, and prevented disruption of tight junction protein occludin in murine models. In vitro, TRPV1 antagonism suppressed capsaicin-induced calcium influx, NF-κB activation, and IL-33 overexpression. CONCLUSIONS: Allergen exposure enhances the secretion of IL-33 in hNECs via the TRPV1-NF-κB pathway, thus compromising epithelial tight junction integrity. Inhibition of TRPV1 can attenuate the effects of allergen-induced innate nasal epithelial responses. Our study offers novel insights into the potential therapeutic targeting of TRPV1 in AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, the Second Hospital, Shanxi Medical University,Taiyuan, China; Key Research Laboratory of Airway Neuroimmunology, Shanxi Province, China.
- Department of Otolaryngology. Longgang E.N.T Hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T, Shenzhen, China.
- Department of Otolaryngology, Xi'an No.3 Hospital, School of Life Sciences and Medicine, Northwest University, Xi'an, China.
- Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Otolaryngology-Head and Neck Surgery, the Second Hospital, Shanxi Medical University,Taiyuan, China; Key Research Laboratory of Airway Neuroimmunology, Shanxi Province, China. Electronic address: fahyj@126…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanxi Provincial Key Research and Development Project
Zitieren
APA
Wang, Y., Qi, X., Li, H., Zhang, H., Zhu, X., Wang, L., Li, F., Duan, H., Fu, S., Zhuo, H., Cheng, F., & Zhao, C. (2025). Inhibition of TRPV1 attenuates innate nasal epithelial responses via NF-κB signaling pathway in allergic rhinitis. International Immunopharmacology, 158, 114807. https://doi.org/10.1016/j.intimp.2025.114807
Vancouver
Wang Y, Qi X, Li H, Zhang H, Zhu X, Wang L, et al. Inhibition of TRPV1 attenuates innate nasal epithelial responses via NF-κB signaling pathway in allergic rhinitis. International Immunopharmacology. 2025;158:114807. doi:10.1016/j.intimp.2025.114807
BibTeX
@article{Wang2025,
author = {Wang, Yanjie and Qi, Xueping and Li, Hanxiong and Zhang, Haoxiang and Zhu, Xiaojia and Wang, Luyao and Li, Feiyang and Duan, Hongying and Fu, Sirui and Zhuo, Hedi and Cheng, Fengli and Zhao, Changqing},
title = {Inhibition of TRPV1 attenuates innate nasal epithelial responses via NF-κB signaling pathway in allergic rhinitis},
journal = {International Immunopharmacology},
year = {2025},
volume = {158},
pages = {114807},
doi = {10.1016/j.intimp.2025.114807}
}
EUVIMED